Nexien Biopharma Inc

PINK:NXEN USA Drug Manufacturers - Specialty & Generic

Market Cap

$990.81K

Market Cap Rank

#45512 Global

#14303 in USA

Share Price

$0.01

Change (1 day)

+0.00%

52-Week Range

$0.01 - $0.01

All Time High

$6.00

Nexien Biopharma Inc - Asset Resilience Ratio

Latest as of December 2024: 100.00%

Nexien Biopharma Inc (NXEN) has an Asset Resilience Ratio of 100.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$1.31 Billion

Cash + Short-term Investments

Total Assets

$1.31 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2018)

This chart shows how Nexien Biopharma Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Nexien Biopharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.31 Billion	100.0%
Total Liquid Assets	$1.31 Billion	100.00%

Asset Resilience Insights

Very High Liquidity: Nexien Biopharma Inc maintains exceptional liquid asset reserves at 100.00% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.